Загрузка...
Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI): characterizing disease severity and assessing responsiveness to clinical change
BACKGROUND: The Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) was developed for use in clinical trials and longitudinal patient assessment. OBJECTIVES: To characterize disease severity using the CDASI and assess responsiveness of this instrument to clinically meaningful changes i...
Сохранить в:
| Опубликовано в: : | Br J Dermatol |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4878996/ https://ncbi.nlm.nih.gov/pubmed/25994337 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjd.13915 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|